April 20, 2022
15 min watch
Save
VIDEO: Hidradenitis suppurativa patient experience, management, care ‘key themes’ at meeting
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Haley Naik, MD, discusses “three key themes” from the hidradenitis suppurativa symposiums at the American Academy of Dermatology Annual Meeting.
Naik, associate professor and director of the hidradenitis suppurativa program at University of California, San Francisco and board member of the U.S. Hidradenitis Suppurativa Foundation, specifically highlighted the experience of patients living with HS, medical and surgical management of HS and collaborative care.
References:
- Naik H, et al. S037 Symposium. Hidradenitis suppurativa/acne inversa (HS/AI): Current medical and surgical management. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
- Andrews R. S037 Symposium. Living with HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
- Garg A. S037 Symposium. Epidemiology and comorbidities of HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
- Goldberg S. S037 Symposium. Surgical management of HS. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
- Kirby JS. S037 Symposium. Medical management of HS with biologic therapies. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
- Lowes MA. S037 Symposium. Pathophysiology of hidradenitis suppurativa. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.
- Naik H. S037 Symposium. Medical management of HS with non-biologic therapies. Presented at: American Academy of Dermatology Annual Meeting; March 25-29, 2022; Boston.